rs10814431

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_203447.4(DOCK8):​c.2340G>C​(p.Leu780Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.245 in 1,610,908 control chromosomes in the GnomAD database, including 49,661 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 4817 hom., cov: 33)
Exomes 𝑓: 0.24 ( 44844 hom. )

Consequence

DOCK8
NM_203447.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 0.298
Variant links:
Genes affected
DOCK8 (HGNC:19191): (dedicator of cytokinesis 8) This gene encodes a member of the DOCK180 family of guanine nucleotide exchange factors. Guanine nucleotide exchange factors interact with Rho GTPases and are components of intracellular signaling networks. Mutations in this gene result in the autosomal recessive form of the hyper-IgE syndrome. Alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 9-377111-G-C is Benign according to our data. Variant chr9-377111-G-C is described in ClinVar as [Benign]. Clinvar id is 137139.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-377111-G-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.298 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.28 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DOCK8NM_203447.4 linkc.2340G>C p.Leu780Leu synonymous_variant Exon 20 of 48 ENST00000432829.7 NP_982272.2 Q8NF50-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DOCK8ENST00000432829.7 linkc.2340G>C p.Leu780Leu synonymous_variant Exon 20 of 48 1 NM_203447.4 ENSP00000394888.3 Q8NF50-1

Frequencies

GnomAD3 genomes
AF:
0.247
AC:
37504
AN:
152070
Hom.:
4812
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.284
Gnomad AMI
AF:
0.330
Gnomad AMR
AF:
0.234
Gnomad ASJ
AF:
0.193
Gnomad EAS
AF:
0.0733
Gnomad SAS
AF:
0.258
Gnomad FIN
AF:
0.181
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.250
Gnomad OTH
AF:
0.256
GnomAD2 exomes
AF:
0.225
AC:
55806
AN:
247598
AF XY:
0.229
show subpopulations
Gnomad AFR exome
AF:
0.284
Gnomad AMR exome
AF:
0.202
Gnomad ASJ exome
AF:
0.210
Gnomad EAS exome
AF:
0.0639
Gnomad FIN exome
AF:
0.185
Gnomad NFE exome
AF:
0.248
Gnomad OTH exome
AF:
0.234
GnomAD4 exome
AF:
0.245
AC:
356785
AN:
1458722
Hom.:
44844
Cov.:
36
AF XY:
0.245
AC XY:
178104
AN XY:
725640
show subpopulations
Gnomad4 AFR exome
AF:
0.281
AC:
9387
AN:
33460
Gnomad4 AMR exome
AF:
0.205
AC:
9172
AN:
44656
Gnomad4 ASJ exome
AF:
0.205
AC:
5359
AN:
26136
Gnomad4 EAS exome
AF:
0.0778
AC:
3086
AN:
39684
Gnomad4 SAS exome
AF:
0.262
AC:
22535
AN:
86176
Gnomad4 FIN exome
AF:
0.184
AC:
9375
AN:
50874
Gnomad4 NFE exome
AF:
0.253
AC:
281388
AN:
1111684
Gnomad4 Remaining exome
AF:
0.246
AC:
14854
AN:
60348
Heterozygous variant carriers
0
17477
34955
52432
69910
87387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
9428
18856
28284
37712
47140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.247
AC:
37522
AN:
152186
Hom.:
4817
Cov.:
33
AF XY:
0.241
AC XY:
17954
AN XY:
74410
show subpopulations
Gnomad4 AFR
AF:
0.284
AC:
0.284027
AN:
0.284027
Gnomad4 AMR
AF:
0.234
AC:
0.233625
AN:
0.233625
Gnomad4 ASJ
AF:
0.193
AC:
0.192684
AN:
0.192684
Gnomad4 EAS
AF:
0.0734
AC:
0.0734387
AN:
0.0734387
Gnomad4 SAS
AF:
0.259
AC:
0.259321
AN:
0.259321
Gnomad4 FIN
AF:
0.181
AC:
0.181106
AN:
0.181106
Gnomad4 NFE
AF:
0.250
AC:
0.250221
AN:
0.250221
Gnomad4 OTH
AF:
0.253
AC:
0.253086
AN:
0.253086
Heterozygous variant carriers
0
1477
2954
4430
5907
7384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.243
Hom.:
940
Bravo
AF:
0.250
Asia WGS
AF:
0.164
AC:
571
AN:
3478
EpiCase
AF:
0.251
EpiControl
AF:
0.259

ClinVar

Significance: Benign
Submissions summary: Benign:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 42% of patients studied by a panel of primary immunodeficiencies. Number of patients: 40. Only high quality variants are reported. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu780Leu in exon 20 of DOCK8: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 28.8% (1271/4406) o f African American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs10814431). -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 27, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1Other:1
-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Combined immunodeficiency due to DOCK8 deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
3.3
DANN
Benign
0.74
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10814431; hg19: chr9-377111; COSMIC: COSV66618101; API